PF
EVGN icon

Phoenix Financial’s Evogene EVGN Stock Holding History

Phoenix Financial’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,041
Closed -$188K – 385
2020
Q3 		$188K Sell
5,041
-21,272
-81% -$380K 0.01% 304
2020
Q2 		$250K Hold
26,313
– – 0.01% 276
2020
Q1 		$303K Hold
26,313
– – 0.02% 268
2019
Q4 		$397K Hold
26,313
– – 0.02% 174
2019
Q3 		$397K Buy
+26,313
New +$414K 0.02% 167

Other funds holding EVGN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Phoenix Financial's EVGN Position: Q4 2020 in Review

Phoenix Financial sold out of Evogene (EVGN) in Q4 2020, closing a stake of 5,041 shares — an estimated $188K sold.

Phoenix Financial first reported a position in EVGN in Q3 2019 and held it in 5 quarters. The position peaked at $397K in Q4 2019. 33 funds tracked by Wall St. Rank hold EVGN as of Q4 2020.

  • Phoenix Financial reported no remaining Evogene position as of Q4 2020 after selling out during the quarter.
  • Phoenix Financial sold 5,041 Evogene shares in Q4 2020, an estimated $188K.
  • Phoenix Financial first reported a position in Evogene in Q3 2019 and held it in 5 quarters.
  • Phoenix Financial's Evogene position peaked at $397K in Q4 2019.
  • 33 funds tracked by Wall St. Rank held Evogene as of Q4 2020.

Based on Phoenix Financial's 13F filing for Q4 2020, filed 11 Feb 2021.